actoferrin versus iron polymaltose for the treatment of iron deficiency anemia in Egyptian children with cerebral palsy

Not Applicable

• Conditions: Mental and Behavioural Disorders; Neonatal Diseases; Nutritional, Metabolic, Endocrine

• Registration Number: PACTR201911857573624
• Lead Sponsor: Pediatrics Department Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-16
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Children with a formal diagnosis of cerebral palsy by a specialist in the management of children with cerebral palsy.
children with cerebral palsy diagnosed with iron deficiency anemia.

Exclusion Criteria

Children who have received oral iron preparations over the previous 6 months.
Children having a medical or family history of beta thalassaemia or haemoglobinopathies.
Children who are currently suffering from an acquired acute infectious illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified